Insulin resistance in essential hypertension. 1987

E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua

High blood pressure is prevalent in obesity and in diabetes, both conditions with insulin resistance. To test whether hypertension is associated with insulin resistance independently of obesity and glucose intolerance, we measured insulin sensitivity (using the euglycemic insulin-clamp technique), glucose turnover (using [3H]glucose isotope dilution), and whole-body glucose oxidation (using indirect calorimetry) in 13 young subjects (38 +/- 2 years [+/- SEM]) with untreated essential hypertension (165 +/- 6/112 +/- 3 mm Hg), normal body weight, and normal glucose tolerance. In the postabsorptive state, all measures of glucose metabolism were normal. During steady-state euglycemic hyperinsulinemia (about 60 microU per milliliter), hepatic glucose production and lipolysis were effectively suppressed, and glucose oxidation and potassium disposal were normally stimulated. However, total insulin-induced glucose uptake was markedly impaired (3.80 +/- 0.32 vs. 6.31 +/- 0.42 mg per minute per kilogram of body weight in 11 age- and weight-matched controls, P less than 0.001). Thus, reduced nonoxidative glucose disposal (glycogen synthesis and glycolysis) accounted for virtually all the defect in overall glucose uptake (1.19 +/- 0.24 vs. 3.34 +/- 0.44 mg per minute per kilogram, P less than 0.001). Total glucose uptake was inversely related to systolic or mean blood pressure (r = 0.76 for both, P less than 0.001). These results provide preliminary evidence that essential hypertension is an insulin-resistant state. We conclude that this insulin resistance involves glucose but not lipid or potassium metabolism, is located in peripheral tissues but not the liver, is limited to nonoxidative pathways of intracellular glucose disposal, and is directly correlated with the severity of hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
January 1990, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
January 1991, Cor et vasa,
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
June 2000, Journal of hypertension,
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
January 1992, Hormone research,
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
May 1994, Casopis lekaru ceskych,
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
September 2013, African health sciences,
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
December 1995, Journal of hypertension,
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
December 1989, European journal of clinical investigation,
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
December 1997, Hypertension (Dallas, Tex. : 1979),
E Ferrannini, and G Buzzigoli, and R Bonadonna, and M A Giorico, and M Oleggini, and L Graziadei, and R Pedrinelli, and L Brandi, and S Bevilacqua
April 1991, American heart journal,
Copied contents to your clipboard!